Investigator Site 37 - ES0340021

Barcelona 08035

0 studies enrolling now · 2 studies all time

What they study most

Generalized Myasthenia Gravis

Studies at this site

• Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis — Completed
• Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis — Completed